Blue Crest Capital Management LTD Arrowhead Pharmaceuticals, Inc. Transaction History

Blue Crest Capital Management LTD

  • $1.79 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$6.37 - $14.02 $1.57 Million - $3.46 Million
-246,490 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$3.72 - $7.64 $639,401 - $1.31 Million
171,882 Added 230.38%
246,490 $1.78 Million
Q4 2017

Feb 14, 2018
BUY
$3.14 - $4.5 $234,269 - $335,736
74,608
74,608 $275,000

Others Institutions Holding ARWR

# of Institutions
296
Shares Held
88.5M
Call Options Held
905K
Put Options Held
387K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.71B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email